TDBOF yields 2.52% · JNJ yields 2.13%● Live data
📍 TDBOF pulled ahead of the other in Year 1
Combined, TDBOF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TDBOF + JNJ for your $10,000?
Toyota Boshoku Corporation manufactures and sells automotive interior systems and products, automotive filter and power train equipment components, automotive components, and fabric goods in Japan, the United States, rest of Asia, Oceania, China, Europe, and Africa. The company offers automobile and aircraft seats, and door trims; headliners, such as molded headliners for a panorama roof, overhead console illumination, and grab handles; and floor carpets, package trays, tonneau covers, and deck boards, as well as exterior components consisting of bumpers, fender liners, and engine undercovers. It also provides filter products, including air and oil filters; and anti-allergen and deodorizing, dust and pollen removal, and anti-bacterial cabins, as well as clean air filters. In addition, the company offers air induction part products, such as air induction systems and cleaners, intake manifolds, oil mist separators, timing chain covers, and cylinder head covers; and fuel cell part products comprising air filter for fuel cell vehicles, ion exchangers, and separators, as well as anti-droplet partition and weets. Further, it provides aircraft and railway seats; and textile components comprising seat fabrics, curtain-shield airbags, and seatbelt webbings. The company was founded in 1918 and is based in Kariya, Japan.
Full TDBOF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.